| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 09, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$32.00
Est. +105%
|
$15.64 | $24.88 |
Pending
|
$23.97
+53.3%
|
| Dec 08, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$138.00
Est. +46%
|
$94.30 | $130.05 |
Pending
|
$113.51
+20.4%
|
| Oct 30, 2025 |
Arvinas Inc
ARVN
|
BUY |
$14.00
Est. +46%
|
$9.59 | $16.14 |
Target Met
|
$8.39
-12.5%
|
| Oct 22, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$75.00
Est. +29%
|
$58.32 | $130.05 |
Target Met
|
$113.51
+94.6%
|
| Oct 10, 2025 |
Perspective Therapeutics Inc
CATX
|
BUY |
$14.00
Est. +233%
|
$4.20 | $6.16 |
Pending
|
$3.63
-13.6%
|
| Sep 09, 2025 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$87.00
Est. +94%
|
$44.93 | $105.00 |
Target Met
|
$97.79
+117.6%
|
| Jun 26, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$59.00
Est. +27%
|
$46.47 | $130.05 |
Target Met
|
$113.51
+144.3%
|
| May 02, 2025 |
Arvinas Inc
ARVN
|
BUY |
$16.00
Est. +107%
|
$7.72 | $16.14 |
Bullseye Hit (±1%)
|
$8.39
+8.7%
|
| Dec 10, 2024 |
Arvinas Inc
ARVN
|
BUY |
$69.00
Est. +181%
|
$24.59 | $25.75 |
Miss
|
$8.39
-65.9%
|